Top 10 videos of 2022
A look back at the year's top videos.
Legal expert weighs in on repercussions of Supreme Court abortion decision
Bethany Corbin, Esq., sits down with Contemporary OB/GYN® to discuss the recent Supreme Court ruling overturning Roe v Wade and striking down almost 50 years of abortion precedent.
BD’s Onclarity HPV Assay: What it means for the future of cervical cancer detection
Pathology expert Mark H. Stoler, MD, discussed the BD Onclarity™ HPV Assay for primary HPV screening and what it means for the future of cervical cancer detection.
Beating burnout: Habit-hacking tips for bringing wellness back into your life
Burnout is uniquely pervasive in medicine, regardless of specialty, making physicians more susceptible than the average person. Matthew T. Siedhoff, MD, MSCR, discusses warning signs to watch for and shares his habit-hacking tips to refocus your routines and bring wellness back into your life.
Tapping into the potential of combined laparoscopic salpingectomy and endometrial ablation
Greg Marchand, MD, talks about his recently published article evaluating the underused potential of combined laparoscopic salpingectomy and endometrial ablation for treatment of abnormal uterine bleeding and desired sterilization.
Myfembree for moderate-to-severe endometriosis pain: Potential for adolescents
Contemporary OB/GYN® sat down with Jessica Shim, MD, an attending at in the Division of Gynecology, Department of Surgery, Boston Children’s Hospital; Harvard Medical School Boston, Massachusetts, to discuss Myfembree (relugolix, estradiol, and norethindrone acetate tablets; Myovant Sciences, Pfizer) and its possible approval in May 2022.
Michal Elovitz, MD, discusses new preterm birth data at SMFM
In this exclusive video interview, Michal Elovitz, MD, chief medical advisor at Mirvie, discusses the latest data from the RNA testing platform in predicting preterm birth at the SMFM 42nd Annual Pregnancy Meeting.
Mirvie RNA test aims to predict pregnancy complications
Maneesh Jain, CEO and co-founder of Mirvie, a proprietary RNA platform that uses blood samples to predict pregnancy complications such as preeclampsia, sits down with Contemporary OB/GYN to discuss the potential of the test.
